Suvorexant for sleep-onset insomnia or sleep-maintenance insomnia, or both

Research output: Contribution to journalArticle

Abstract

Suvorexant, FDA-approved to treat insomnia, has demonstrated efficacy in helping patients with insomnia improve their ability to fall asleep and remain asleep (Table 1).1 This first-in-class compound represents a novel mechanism of action to promoting sleep that may avoid some problems associated with other hypnotics.2.

Original languageEnglish (US)
Pages (from-to)19-24
Number of pages6
JournalCurrent Psychiatry
Volume14
Issue number1
StatePublished - 2015

ASJC Scopus subject areas

  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Suvorexant for sleep-onset insomnia or sleep-maintenance insomnia, or both'. Together they form a unique fingerprint.

  • Cite this